Therapeutic Advances in Chronic Disease

Impact Factor: 2.8

Editor-In-Chief: N/A

Discipline: Clinical Medicine

Description:

Journal Highlights  Launched in 2010 Gold open access journal – all articles are made freely available online immediately upon publication Rigorous peer review Listed in PubMed and indexed in Web of Science, Science Citation Index Expanded (SCIE) and Scopus Reaches a broad, multidisciplinary audience Over 600 000 full-text article views annually Sage Open Chronic Disease is a peer-reviewed open access journal which focuses on the highest quality research, reviews and scholarly comment on pioneering efforts and innovative studies across all chronic diseases. The journal has a strong clinical and pharmacological focus and is aimed at clinicians and researchers, providing a forum in print and online for publishing the highest quality articles in this area. Please see the Aims and Scope tab for further information. This journal is a member of the Committee on Publication Ethics (COPE).   Diversity, Equity and Inclusion Statement Sage Open Chronic Disease promotes inclusive, open science that reflects the disciplinary, human, and geographic diversity of the chronic disease community. Diversity as a core value embodies inclusiveness, mutual respect, and multiple perspectives. We welcome editors, editorial board members, peer reviewers and authors from all backgrounds, cultures, ethnicities, nationalities, races, religions, sexes, sexual orientations, gender identities, mental or physical (dis)abilities, ages, career stages, socioeconomic status or any other individual status. We are committed to continually improving our editorial and review processes whilst playing our part in eradicating bias and inequality in all forms.Submission informationSubmit your manuscript today at http://mc.manuscriptcentral.com/tacd. Please see the Submission Guidelines tab for more information on how to submit your article to the journal. Open access article processing charge (APC) information Unsolicited manuscripts submitted to Therapeutic Advances in Chronic Disease are currently subject to an Article Processing Charge (APC) of 3000 USD payable upon acceptance. These articles will be published under a Creative Commons license and will be made openly available.  The article processing charge (APC) is payable when a manuscript is accepted after peer review, before it is published. The APC is subject to taxes where applicable. Please see further details here.ContactPlease direct any queries to TAChronicDisease@sagepub.com.